GST Council not for inclusion of petroleum products: Finance Minister
Rajat Bose
With new ‘industrial relations’ code, what does the future look like for India’s trade unions?
Soumya Jha and Ulka Bhattacharyya
Shardul Amarchand Mangaldas & Co. advises Biocon Biologics Limited to offer 15% stake to Serum Institute Life Sciences for accessing 100 million doses of vaccines per annum for 15 years
Shardul Amarchand Mangaldas & Co. advised Biocon Biologics Limited (“BBL”), a subsidiary of Biocon Limited, pursuant to which BBL will offer approximately 15% stake to Serum Institute Life Sciences Private Limited (“SILS”) at a post-money valuation of USD 4.9 billion, for accessing 100 million doses of vaccines per annum for 15 years, primarily from SILS’s… Read More +